Watchlist Price Alert

LifeMD Inc. (LFMD)

NASDAQ: LFMD · Real-Time Price · USD

13.44

0.98 (7.87%)

At close: Jun 16, 2025, 3:59 PM

13.60

1.19%

After-hours: Jun 16, 2025, 07:59 PM EDT

7.87% (1D)

Bid	13.41
Market Cap	610.82M
Revenue (ttm)	220.89M
Net Income (ttm)	-11.51M
EPS (ttm)	-0.33
PE Ratio (ttm)	-40.73
Forward PE	44.5
Analyst	Buy

Ask	13.6
Volume	1,642,235
Avg. Volume (20D)	1,670,280
Open	12.59
Previous Close	12.46
Day's Range	12.59 - 13.76
52-Week Range	3.99 - 13.76
Beta	2.43

About LFMD

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol LFMD

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for LFMD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

1 month ago

+3.22%

LifeMD shares are trading higher after the company... Unlock content with Pro Subscription

1 month ago

+41.31%

LifeMD shares are trading higher after the company announced it will offer access to Wegovy.

News

1 week ago · seekingalpha.com

LifeMD: Growth, Growth, And More Growth

LifeMD is experiencing a major growth inflection, with record Q1 revenue, first-ever GAAP profitability, and strong subscriber and margin gains. Multiple growth drivers - including GLP-1 programs, Med...

1 month ago · seekingalpha.com

LifeMD, Inc. (LFMD) Q1 2025 Earnings Call Transcript

LifeMD, Inc. (NASDAQ:LFMD ) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants Justin Schreiber - Chairman and CEO Marc Benathen - Chief Financial Officer Conference Call Par...

1 month ago · zacks.com

LifeMD, Inc. (LFMD) Q1 Earnings and Revenues Top Estimates

LifeMD, Inc. (LFMD) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to loss of $0.19 per share a year ago.

1 month ago · fool.com

Why Hims & Hers Health and LifeMD Are Skyrocketing Today

Shares of Hims & Hers Health (HIMS 25.46%) and LifeMD (LFMD 35.41%) are surging on Tuesday. The companie' stocks had jumped 24% and 34%, respectively, as of 3:15 p.m.

1 month ago · businesswire.com

Medifast Announces First Quarter 2025 Financial Results

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ...

2 months ago · seekingalpha.com

LifeMD Is Back To Life

LifeMD's weight management segment is regaining competitiveness due to the end of GLP-1 compound shortages and expanded insurance coverage, including Medicare. The company is seeing significant growth...